What drives the heterogeneity in cerebral atrophic rates among MCI patients with similar clinical presentations?

OPEN

While the study identifies two distinct atrophy classes in MCI and links them to microglia proteins, the upstream factors determining why some patients follow slow versus fast atrophy trajectories remain unknown. Understanding these drivers could enable early stratification. Gap type: unexplained_observation Source paper: Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins related to microglia activity on longitudinal cognitive changes. (2024, Archives of gerontology and geriatrics, PMID:39079281)

Priority: 0.82 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What drives the heterogeneity in cerebral atrophic rates among MCI patients with similar clinical presentations? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What drives the heterogeneity in cerebral atrophic rates among MCI patients with similar clinical presentations? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

biomarker for (1)

h-527d32c9MCI
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps